• 1
    Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993;328: 18494.
  • 2
    Paterson IC, Eveson JW, Prime SS. Molecular changes in oral cancer may reflect aetiology and ethnic origin. Oral Oncol Eur J Cancer 1996;32B: 1503.
  • 3
    Silverman S, Gorsky Jr. M, Lozada F. Oral leukoplakia and malignant transformation: a follow up study of 257 patients. Cancer 1984;53: 5638.
  • 4
    Tradati N, Grigolat R, Calabrese L. Oral leukoplakias: to treat or not? Oral Oncol Eur J Cancer 1997;33: 31721.
  • 5
    Shindoh M, Chiba I, Yasuda M, et al. 1995. Detection of HPV DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer 1995;76: 151321.
  • 6
    Paz JB, Cook N, Odom-Maryon T, et al. 1997. Human papillomavirus (HPV) in head and neck cancer: an association of HPV-16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;9: 595604.
  • 7
    Balram P, Nalinakumar KR, Abraham B, et al. Human papilloma virus in 91 oral Indian betel quid chewers: high prevelance and multiplicity of infections. Int J Cancer 1995;61: 4504.
  • 8
    Costa DJ, Saranath D, Dedhia P, et al. 1998. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol Eur J Cancer 1998;34: 41320.
  • 9
    Zur Hausen H. 1991. Viruses in human cancer. Science 1991;254: 116773.
  • 10
    D as BC, Gopalkrishna V, Hedau S, Katiyar S. Cancer of the uterine cervix and human papillomavirus infection. Curr Sci 2000;78: 5263.
  • 11
    Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered 1994;44: 266270.
  • 12
    Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus associated cancer. Nature (Lond) 1998;393: 22934.
  • 13
    Makni H, Franco EL, Kaiano J, et al. p53 polymorphism in codon 72 and risk of human papillomavirus induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 2000;87: 52833.
  • 14
    Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acid Res 1976;3: 2303.
  • 15
    Wright DK, Manos MM. Sample preparation from paraffin embedded tissue. In: InnisMA, GelfandDH, SninskyJJ, WhiteTJ, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990. 1537.
  • 16
    Ting GS, Manos MM. Detection and typing of genital human papilloma virus. In: InnisMA, GelfandDH, SninskyJJ, WhiteTJ, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990. 35667.
  • 17
    Cruz IBF, Snijders PJF, Steenbergen RDM, et al. Age dependence of human papilloma virus DNA presence in oral squamous cell carcinoma. Oral Oncol Eur J Cancer 1996;32B: 5562.
  • 18
    Hildesheim A, Schiffman M, Brinton LA, et al. p53 polymorphism and risk of cervical cancer. Nature (Lond) 1998;396: 5312.
  • 19
    Duin M, Snijders PJF, Vossen MTM, et al. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 2000;81: 31725.
  • 20
    Minaguchi T, Kanamori Y, Matsushima M, et al. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 1998;58: 45846.
  • 21
    Murata M, Tagawa M, Kimura H, et al. Correlation of the mutation of p53 gene and the polymorphism at codon 72 in smoking related non-small cell lung cancer patients. Int J Oncol 1998;12: 57781.
  • 22
    Wang Y-C, Chen C-Y, Chen S-K, et al. p53 Codon 72 polymorphism in Taiwanese Lung Cancer Patients: Association with lung cancer susceptibility and prognosis. Clin Cancer Res 1999;5: 12934.
  • 23
    Weston A, Ling-Cawley HM, Caporaso NE, et al. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis (Lond) 1994;15: 5857.
  • 24
    To-Figueras J, Gene M, Gomez-Catalan J, et al. Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomark Prev 1996;5: 33742.
  • 25
    Murata M, Tagawa M, Kimura M, et al. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients: discrete results with smoking history. Carcinogenesis (Lond) 1996;17: 2614.
  • 26
    Jin X, Wu X, Roth JA, et al. Higher lung cancer risk for younger African-Americans with the Pro/ Pro p53 genotype. Carcinogenesis (Lond) 1995;16: 22058.
  • 27
    Kawaguchi H, Ohno S, Araki K, et al. p53 polymorphism in Human Papillomavirus associated Esophageal Cancer. Cancer Res 2000;60: 27535.
  • 28
    Hamel N, Black MJ, Ghadirian P, et al. No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 2000;82: 7579.
  • 29
    Marin MC, Jost CA, Brooks LA, et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 2000;25: 4754.